TG Medical OÜ

Active Registry code 16288109 OÜ Tallinn Registered 9 Aug 2021
Compare

TG Medical OÜ is a OÜ based in Tallinn, registry code 16288109, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with 1 employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
1
±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q2 2025: 0 € · industry median 1 781 € · above 2% of the industry
05001 0001 5002 0002 500Q4 2023 Company: 0 € Industry median: 1 866 €Q4·23Q1 2024 Company: 0 € Industry median: 2 040 €Q2 2024 Company: — Industry median: 2 008 €Q2·24Q3 2024 Company: — Industry median: 1 961 €Q4 2024 Company: — Industry median: 1 673 €Q4·24Q1 2025 Company: — Industry median: 1 781 €Q2 2025 Company: 0 € Industry median: 1 781 €Q2·25Q3 2025 Company: — Industry median: 2 044 €Q4 2025 Company: — Industry median: 2 069 €Q4·25Q1 2026 Company: — Industry median: 2 039 €Q2 2026 Company: — Industry median: 1 893 €Q2·26Q3 2026 Company: — Industry median: 2 218 €Q3·2605001 0001 5002 0002 500Q4 2024 Company: — Industry median: 1 673 €Q1 2025 Company: — Industry median: 1 781 €Q1·25Q2 2025 Company: 0 € Industry median: 1 781 €Q3 2025 Company: — Industry median: 2 044 €Q3·25Q4 2025 Company: — Industry median: 2 069 €Q1 2026 Company: — Industry median: 2 039 €Q1·26Q2 2026 Company: — Industry median: 1 893 €Q3 2026 Company: — Industry median: 2 218 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 1 · +0.0% vs Q2 2026
0.00.20.40.60.81.0Q4 2023 Company: 1Q4·23Q1 2024 Company: 1Q2 2024 Company: 1Q2·24Q3 2024 Company: 1Q4 2024 Company: 1Q4·24Q1 2025 Company: 1Q2 2025 Company: 1Q2·25Q3 2025 Company: 1Q4 2025 Company: 1Q4·25Q1 2026 Company: 1Q2 2026 Company: 1Q2·26Q3 2026 Company: 1Q3·260.00.20.40.60.81.0Q4 2024 Company: 1Q1 2025 Company: 1Q1·25Q2 2025 Company: 1Q3 2025 Company: 1Q3·25Q4 2025 Company: 1Q1 2026 Company: 1Q1·26Q2 2026 Company: 1Q3 2026 Company: 1Q3·26
State taxes, € Q2 2025: 1 128 €
02505007501 0001 250Q4 2023 Company: 500 €Q4·23Q1 2024 Company: 750 €Q2 2024 Company: —Q2·24Q3 2024 Company: —Q4 2024 Company: —Q4·24Q1 2025 Company: —Q2 2025 Company: 1 128 €Q2·25Q3 2025 Company: —Q4 2025 Company: —Q4·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·2602505007501 0001 250Q4 2024 Company: —Q1 2025 Company: —Q1·25Q2 2025 Company: 1 128 €Q3 2025 Company: —Q3·25Q4 2025 Company: —Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — 1
Q2 2026 — — — 1
Q1 2026 — — — 1
Q4 2025 — — — 1
Q3 2025 — — — 1
Q2 2025 — 1 128 — 1
Q1 2025 — — — 1
Q4 2024 — — — 1
Q3 2024 — — — 1
Q2 2024 — — — 1
Q1 2024 — 750 — 1
Q4 2023 — 500 — 1
Q3 2023 — 750 — 1
Q2 2023 — — — 1
Q1 2023 — — — 1
Q4 2022 — — — 1
Q3 2022 — — — 1
Q2 2022 — — — 1
Q1 2022 1 329 — — 1
Turnover per employee in the quarter
0 €

Q3 2026 · calculated from EMTA data

Financials by year

2022 – 2025
Revenue, € 2025: 0 € · −100.0% vs 2024 · industry median 0 € · above 5% of the industry
05 00010 00015 00020 0002022 Company: 19 135 € Industry median: 103 €20222023 Company: 16 180 € Industry median: 76 €20232024 Company: 11 912 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €202505 00010 00015 00020 0002022 Company: 19 135 € Industry median: 103 €2023 Company: 16 180 € Industry median: 76 €20232024 Company: 11 912 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -1 946 € · −118.5% vs 2024 · industry median 0 € · above 18% of the industry
-5 00005 00010 00015 0002022 Company: 14 162 € Industry median: 0 €20222023 Company: 12 974 € Industry median: 0 €20232024 Company: 10 533 € Industry median: 0 €20242025 Company: -1 946 € Industry median: 0 €2025-5 00005 00010 00015 0002022 Company: 14 162 € Industry median: 0 €2023 Company: 12 974 € Industry median: 0 €20232024 Company: 10 533 € Industry median: 0 €2025 Company: -1 946 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2024: 88.4 % · +8.2 pp vs the year before · industry median 15.8 % · above 90% of the industry
0204060801002022 Company: 74.0 % Industry median: 17.7 %20222023 Company: 80.2 % Industry median: 16.8 %20232024 Company: 88.4 % Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %20250204060801002022 Company: 74.0 % Industry median: 17.7 %2023 Company: 80.2 % Industry median: 16.8 %20232024 Company: 88.4 % Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 23 723 € · −20.0% vs 2024
010 00020 00030 0002022 Company: 14 422 €20222023 Company: 19 886 €20232024 Company: 29 669 €20242025 Company: 23 723 €2025010 00020 00030 0002022 Company: 14 422 €2023 Company: 19 886 €20232024 Company: 29 669 €2025 Company: 23 723 €2025
Equity, € 2025: 23 723 € · −20.0% vs 2024
010 00020 00030 0002022 Company: 14 162 €20222023 Company: 19 136 €20232024 Company: 29 669 €20242025 Company: 23 723 €2025010 00020 00030 0002022 Company: 14 162 €2023 Company: 19 136 €20232024 Company: 29 669 €2025 Company: 23 723 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 -1 946 0 23 723 23 723 0
2024 11 912 10 533 0 29 669 29 669 0
2023 16 180 12 974 0 19 886 19 136 0
2022 19 135 14 162 0 14 422 14 162 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-8.2 %
Net profit / equity
Return on assets (ROA)
-8.2 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 19 May 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 27 May 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 5 Jun 2024 Company’s own e-Äriregister
2022 9 Aug 2021 – 31 Dec 2022 15 May 2023 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main

Rulings 2

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50180151 / 2
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50180151
9 Aug 2021
 First entry In force
9 Aug 2021
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data